Hikma Pharmaceuticals Share News (HIK)
HIK Share
HIK Share
HIK Share
HIK Share
HIK
HIK Share
HIK Level 2
HIK Live
HIK Broker
HIK Directors
HIK Financial
HIK
HIK Short
HIK
Last checked at -
(Sharecast News) - Hikma Pharmaceuticals grew 2018 sales and profits much more than it had expected at the start of last year, but final numbers and guidance for 2019 from the speciality and generic drug maker were both a little short of upgraded market forecasts.
Read more
LONDON (Alliance News) - Stock prices in London are set to open lower on Wednesday, while the pound was steady after UK Prime Minister Theresa May's latest defeat in Parliament over her Brexit
Read more(Sharecast News) - Investors may be facing heightened volatility on Wednesday, as financial markets digest the result of Parliament's vote on Theresa May's proposal for the UK's withdrawal agreement with the European Union.
Read moreLONDON (Alliance News) - Hikma Pharmaceuticals PLC on Tuesday announced the former head of the US businesses of Ipsen and Eisai will be joining as a non-executive director.Cynthia Schwalm a
Read moreThursday 7 March Melrose IndustriesFull Year ResultsNMC HealthFull Year Year Year Year 8
Read more(Sharecast News) - Shares in tobacco companies rose on Wednesday after America's chief drug and tobacco regulator unexpectedly resigned overnight.
Read moreLONDON (Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it has launched cancer treatment Mitomycin as an injection in the US.Mitomycin, administered in doses of either 20 or 40 a
Read more(Sharecast News) - Hikma Pharmaceuticals announced on Tuesday that its Hikma Pharmaceuticals USA division, formerly known as West-Ward Pharmaceuticals, has launched Mitomycin for Injection, USP' at dosages of 20mg and 40mg.
Read more(Sharecast News) - Hikma Pharmaceuticals' US subsidiary has launched a generic equivalent to Lundbeck's Onfi, which is used for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients of two years and older.
Read more(Sharecast News) - Morgan Stanley upped its stance on Smith & Nephew to 'overweight' from 'equalweight' on Monday, lifting the target price to 1,692p from 1,457p as it argued that new management should help to reinvigorate the top line performance following years of stagnation.
Read moreLONDON (Alliance News) - Hikma Pharmaceuticals PLC on Monday said its US unit has launched Clobazam oral suspension and Clobazam tablets, the generic equivalent to Onfi.Clobazam is the name
Read more(Sharecast News) - Jefferies has adopted a more cautious approach to blue chip NMC Health, cutting its rating to 'underperform' over a range of concerns, including corporate governance.
Read more(Sharecast News) - Pets At Home Group: Liberum downgrades to hold with a target price of 120p.
Read moreLONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - HBC, up 5.5%. UBS raised the soft drinks to
Read more(Sharecast News) - Hikma Pharmaceuticals has announced a five-year licensing and supply agreement with China's Hansoh Pharmaceutical Group.
Read more
Last checked at